Topic Archives: Advaxis (ADXS)

The Disruptors and Dominators newsletter, one of the “entry level” letters from Weiss, is out pitching a “silver bullet” company — a firm that has developed a universal cancer vaccine. And, of course, they’ll tell you all about it — for your $49 subscription fee. Here at Stock Gumshoe, we’d like you to think things […]

Comments

  • Resverlogix has no ongoing clinical trial on the ClinicalTrials.gov site. Not sure what they are addressing. There are s...

  • For those considering Advaxis (ADXS) which Dr.KSS and Jean-Pierre Ruiz discussed earlier I found some non-scientific inf...

  • I appreciate JP Ruiz mining so much helpful information on Advaxis $ADXS. This company is a play on the immune stimul...

  • Advaxis (ADXS) is listed on the NASDAQ. It's 52-week range is $2.46 - $5.99 with average volume of 250,914 shares. Marke...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info